NASDAQ · Medical - Devices

RXST (RXST) Stock

$5.64 +8.67% NASDAQ: RXST Healthcare

Valuation

MetricValue
Price$5.64
Market Cap$233.48M
P/E Ratio-5.98
P/B Ratio0.85
P/S Ratio1.95
EPS (TTM)$-0.95
52-Week High$14.25
52-Week Low$4.48
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-14.13%
ROA-12.50%
ROCE-17.39%
Gross Margin-36.57%
Operating Margin-35.82%
Net Margin-36.58%
Debt/Equity0.04
Current Ratio11.04

Annual Financials (USD)

Metric20212022202320242025
Revenue$23.0M$49.0M$89.0M$140.0M$134.0M
Operating Profit$-53.0M$-63.0M$-50.0M$-37.0M$-48.0M
Net Profit$-49.0M$-67.0M$-49.0M$-27.0M$-39.0M
EPS$-1.78$-2.41$-1.41$-0.71$-0.95
Op Margin-233.6%-129.2%-56.2%-26.3%-35.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$193.0M$150.0M$183.0M$319.0M$312.0M
Total Liabilities$54.0M$60.0M$22.0M$37.0M$36.0M
Cash$24.0M$12.0M$10.0M$17.0M$20.0M
Borrowings$45.0M$45.0M$3.0M$12.0M$11.0M

Latest News

RxSight Names Aziz Mottiwala as CEO MT Newswires · Jul 15, 2026 RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer GlobeNewswire · Jul 15, 2026 RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook MarketBeat · Jul 11, 2026 Can Alcon Inc. (ALC) Stock Rebound as New Eye Care Products Approach Regulatory Milestones? Insider Monkey · Jul 8, 2026 Alcon, RxSight Launch Collaboration to Develop Adjustable Presbyopia-Correcting Lenses MT Newswires · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-45.0M$-59.0M$-42.0M$-17.0M$-16.0M
Investing Cash Flow$-84.0M$38.0M$-27.0M$-105.0M$13.0M
Financing Cash Flow$1.0M$-1.0M$-4.0M$-6.0M$-2.0M
Net Cash Flow$11.0M$-13.0M$-2.0M$7.0M$3.0M
Free Cash Flow$-47.0M$-61.0M$-46.0M$-22.0M$-19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-8.69%
Quick Ratio8.93
Interest Coverage—
Return 1Y-32.03%
Return 3Y-82.48%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About RXST

RXST is led by CEO Ronald Kurtz, employs 498 people, headquartered in US, publicly traded since 2021.

RXST stock trades at $5.64 with a market capitalization of $233.48M. The stock is valued at a price-to-earnings (P/E) ratio of -5.98, price-to-book of 0.85, price-to-sales of 1.95. Over the past 52 weeks the stock has ranged between $4.48 and $14.25, and currently trades 60.4% below its 52-week high.

On profitability, RXST generates a return on equity (ROE) of -14.13%, return on capital employed of -17.39%, an operating margin of -35.82%, a net profit margin of -36.58%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides